Oral News and Research

RSS

Chronic cigarette smoking is associated with diminished folate status

Every year, nearly 300,000 people worldwide are diagnosed with oral cancer.

8 Aug 2006

New screening program effectively roots out toddlers' cavities

Dental researchers are combining the ease of digital photography with the Internet to develop a new and inexpensive way to screen for a common childhood oral disease.

8 Aug 2006

Low-fat vegan diet treats type 2 diabetes more effectively than a standard diabetes diet

Study participants on the low-fat vegan diet showed dramatic improvement in four disease markers: blood sugar control, cholesterol reduction, weight control, and kidney function.

8 Aug 2006

Tocotrienol - a potent neuroprotective agent

Two recent studies offer new evidence suggesting an alternative form of natural vitamin E can be taken by mouth and will reach the blood in humans at levels determined to protect against stroke and other diseases.

6 Aug 2006

Pennsylvania starts annual oral rabies vaccination baiting

Pennsylvania Agriculture Secretary Dennis Wolff today announced that the annual oral rabies vaccination baiting (ORV) program, which helps control rabies in wild animals, will begin on Monday, Aug. 7.

4 Aug 2006

Osteonecrosis of the jawbone and oral bisphosphonates

People taking oral bisphosphonates, a type of drug used to treat osteoporosis, osteopenia and Paget's disease of bone, should be aware of potential risks when undergoing certain dental procedures, according to guidelines published in this month's Journal of the American Dental Association (ADA).

4 Aug 2006

Stopping antiretroviral therapy in HIV-infected patients could be beneficial

Stopping antiretroviral therapy in HIV-infected patients from time to time could reduce the side effects and costs of the treatment, according to a study in this week's issue of The Lancet.

3 Aug 2006

FDA approves Keppra (levetiracetam) for epilepsy treatment

UCB has announced that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) injection for use as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy.

2 Aug 2006

Oral cancers - smoke and drink and up goes the risk!

Scientists in the UK have discovered that mouth cancer develops in two distinct ways which decides just how the serious the disease will be.

2 Aug 2006

Strong link between specific genetic variations and an increased risk of stroke in younger women

University of Maryland researchers have shown a strong association between specific genetic variations and an increased risk of stroke in younger women, adding to the growing evidence of possible genetic influences in stroke.

2 Aug 2006

Polio making a comeback

The World Health Organization (WHO) says increasing numbers of people around the world are vulnerable to polio because they have not been previously exposed to the disease.

30 Jul 2006

Deadly duo of crime and drug abuse can be cut by effective treatments

According to a landmark scientific report released by the National Institute on Drug Abuse (NIDA), money would be saved and crime would be reduced if communities put into place effective treatments for drug abuse and addiction.

26 Jul 2006

Interaction of proteins in the intestinal system may be allergic indicators

Researchers have identified one of the proteins that may be responsible for causing food allergies, which could lead to the development of more accurate non-invasive tests to identify true food allergies.

25 Jul 2006

Cigarette smoking appears to promote the consumption of alcohol

Nicotine can reduce blood alcohol concentrations (BACs) at dosage levels that could be achieved by human smokers.

25 Jul 2006

Genetic key to treating deadly fungal infections

University of Minnesota researchers have discovered how a prevalent fungal pathogen that causes 10,000 deaths per year in the United States overcomes the effects of antifungal drugs by duplicating a section of one of its chromosomes.

24 Jul 2006

Nexavar approved in Europe for treatment of advanced kidney cancer

Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc have announced that the European Commission has granted marketing authorization to Nexavar (sorafenib) tablets for the treatment of patients with advanced renal cell carcinoma.

24 Jul 2006

New natural contraceptive pill being trialled

University of Adelaide researchers, together with the Adelaide Hormone and Menopause Centre, are trialling a new natural contraceptive pill alternative.

24 Jul 2006

New 'patch' drug therapy for Alzheimer's has fewer side effects

Alzheimer's, is the most common form of dementia and affects as many as 15 million people worldwide.

20 Jul 2006

Highly active antiretroviral therapies associated with reduced infections in HIV-infected children

Since the introduction of highly active antiretroviral therapies, there has been a substantial reduction of opportunistic infections and other infections in HIV-infected children, such as pneumonia and tuberculosis.

19 Jul 2006

Roswell Park research aids development of myeloma drug

Roswell Park Cancer Institute (RPCI) researchers played a leading role in clinical studies which led to U.S. Food and Drug Administration (FDA) approval of a new treatment for patients diagnosed with multiple myeloma - the second most common blood cancer.

11 Jul 2006